Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels

Osteoarthritis and Cartilage

Volumn 17, Issue 8, 2009, Pages 1049-1055

  Ahmad, R ^a   El Mabrouk, M ^a   Sylvester, J ^a   Zafarullah, M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Interferon gamma; Matrix metalloproteinase 13; Osteoarthritis; Receptor; Signal transduction

Indexed keywords

COLLAGENASE 3; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; INTERLEUKIN 1; MESSENGER RNA; STAT1 PROTEIN;

ADULT; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CASE REPORT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOTAL HIP PROSTHESIS;

CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OSTEOARTHRITIS; RECEPTORS, INTERFERON;

EID: 67650444353     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.02.008     Document Type: Article

References (15)

1. Zwerina J., Redlich K., Polzer K., Joosten L., Kronke G., Distler J., et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A 104 (2007) 11742-11747
2. Dahlberg L., Billinghurst R.C., Manner P., Nelson F., Webb G., Ionescu M., et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 43 (2000) 673-682
3. Kageyama Y., Koide Y., Yoshida A., Uchijima M., Arai T., Miyamoto S., et al. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161 (1998) 1542-1548
4. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158 (1997) 5501-5506
5. Veys E.M., Menkes C.J., and Emery P. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 40 (1997) 62-68
6. Williams A.S., Richards P.J., Thomas E., Carty S., Nowell M.A., Goodfellow R.M., et al. Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum 56 (2007) 2244-2254
7. Ahmad R., Qureshi H.Y., El Mabrouk M., Sylvester J., Ahmad M., and Zafarullah M. Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma. Ann Rheum Dis 66 (2007) 782-789
8. Liacini A., Sylvester J., Li W.Q., Huang W., Dehnade F., Ahmad M., et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288 (2003) 208-217
9. Ivashkiv L.B., and Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?. Arthritis Rheum 48 (2003) 2092-2096
10. Kelchtermans H., De Klerck B., Mitera T., Van Balen M., Bullens D., Billiau A., et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther 7 (2005) R402-R415
11. Dolhain R.J., ter Haar N.T., Hoefakker S., Tak P.P., de Ley M., Claassen E., et al. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br J Rheumatol 35 (1996) 24-32
12. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
13. Walker J.G., Ahern M.J., Coleman M., Weedon H., Papangelis V., Beroukas D., et al. Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann Rheum Dis 65 (2006) 149-156
14. Kasperkovitz P.V., Verbeet N.L., Smeets T.J., van Rietschoten J.G., Kraan M.C., van der Pouw Kraan T.C., et al. Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 63 (2004) 233-239
15. Hu X., Ho H.H., Lou O., Hidaka C., and Ivashkiv L.B. Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J Immunol 175 (2005) 131-138